Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04508140
Status:
TERMINATED
Last Update Posted:
2022-12-13
First Post:
2020-08-05
Brief Title:
Study of BO-112 With Pembrolizumab for Colorectal or GastricGEJ Cancer With Liver Metastasis
Sponsor:
Highlight Therapeutics
Organization:
Highlight Therapeutics
Organization Data
Organization:
Highlight Therapeutics
Class:
INDUSTRY
Study ID:
BOT112-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Highlight Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None